Related content

Synthesis and pharmacology of the putative novel muscarinic agonist (S)-4-F-MePyMcN [(S)-4-(pyrrolidino)-1-methyl-2-butynyl-N-(4-fluorophenyl) carbamate oxalate]

By Athmani S.   Bradley K.N.   Harvey A.L.   Kornisiuk E.   Jerusalinsky D.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 935-941

Elsevier

Access to resources Recommend Favorite

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M 1 receptors

By Messer W.S.   Rajeswaran W.G.   Cao Y.   Zhang H.-J.   El-Assadi A.A.   Dockery C.   Liske J.   O'Brien J.   Williams F.E.   Huang X.-P.   Wroblewski M.E.   Nagy P.I.   Peseckis S.M.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

Preclinical pharmacology of B-20991, a 5-HT 1A receptor agonist with anxiolytic activity

By Beneytez M.E.   Lopez Rodrguez M.L.   Rosado M.L.   Morcillo M.J.   Orensanz L.   Fuentes J.A.   Manzanares J.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 127-135

Elsevier

Access to resources Recommend Favorite

Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells

By Brauner-Osborne H.   Brann M.R.  

European Journal of Pharmacology, Vol. 295, Iss. 1, 1996-01 ,pp. : 93-102

Elsevier

Access to resources Recommend Favorite

Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M 1 receptors following prolonged agonist treatment

By Cuadra A.E.   El-Fakahany E.E.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite